Hisashi Yamanaka Selected Research

Hisashi Yamanaka Research Topics

Disease

199	Rheumatoid Arthritis 08/2022 - 04/2002
21	Gout 12/2021 - 08/2005
17	Infections 02/2022 - 01/2005
15	Hyperuricemia 12/2021 - 01/2003
15	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2019 - 07/2010
15	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017 - 11/2003
14	Dermatomyositis (Dermatopolymyositis) 07/2019 - 07/2010
11	Pain (Aches) 09/2020 - 12/2005
8	Drug-Related Side Effects and Adverse Reactions 05/2020 - 12/2002
7	Arthritis (Polyarthritis) 01/2018 - 01/2010
6	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 05/2011
5	Herpes Zoster 04/2022 - 10/2014
5	Gouty Arthritis 01/2021 - 09/2002
5	Osteoporosis 01/2021 - 01/2009
5	Neoplasms (Cancer) 10/2020 - 09/2012
5	Melanoma (Melanoma, Malignant) 01/2018 - 09/2012
5	Myositis (Idiopathic Inflammatory Myopathies) 01/2018 - 07/2012
5	Inflammation (Inflammations) 08/2017 - 01/2007
5	Autoimmune Diseases (Autoimmune Disease) 08/2017 - 07/2008
4	Lupus Nephritis 01/2020 - 08/2011
4	Fibrosis (Cirrhosis) 01/2019 - 09/2010
4	Polymyositis 01/2018 - 10/2010
4	Rheumatic Diseases (Rheumatism) 11/2017 - 01/2007
3	Vitamin D Deficiency 01/2021 - 07/2013
3	Psoriatic Arthritis 06/2019 - 10/2012
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 01/2015
3	Synovitis 01/2018 - 01/2009
3	Pneumonia (Pneumonitis) 10/2011 - 06/2010
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2020 - 07/2014

Drug/Important Bio-Agent (IBA)

46	Methotrexate (Mexate)FDA LinkGeneric 04/2022 - 04/2002
30	Biological ProductsIBA 08/2022 - 01/2007
28	Antirheumatic Agents (DMARD)IBA 08/2022 - 12/2002
23	Uric Acid (Urate)IBA 12/2021 - 09/2002
19	Adalimumab (Humira)FDA Link 05/2020 - 04/2011
17	Pharmaceutical PreparationsIBA 03/2022 - 12/2002
16	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 01/2007
16	tocilizumab (atlizumab)FDA Link 05/2020 - 04/2011
14	Etanercept (Enbrel)FDA Link 03/2020 - 01/2006
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2021 - 01/2006
13	Monoclonal AntibodiesIBA 07/2021 - 01/2008
12	Proteins (Proteins, Gene)FDA Link 11/2019 - 03/2007
10	Infliximab (Remicade)FDA Link 07/2022 - 01/2007
10	ametantrone (HAQ)IBA 02/2022 - 12/2005
10	AntibodiesIBA 01/2018 - 06/2011
9	Certolizumab Pegol FDA Link 03/2020 - 07/2014
9	AutoantibodiesIBA 01/2018 - 06/2011
9	CytokinesIBA 08/2017 - 07/2008
8	Febuxostat FDA Link 12/2021 - 06/2011
8	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018 - 12/2011
7	Denosumab FDA Link 11/2021 - 06/2016
7	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 10/2010
7	Prednisolone (Predate)FDA LinkGeneric 05/2020 - 06/2011
7	Rheumatoid FactorIBA 11/2019 - 01/2007
6	Abatacept (Orencia)FDA Link 08/2022 - 09/2014
6	EpitopesIBA 11/2019 - 01/2012
6	golimumab FDA Link 09/2018 - 06/2012
6	Ferritins (Ferritin)IBA 01/2018 - 07/2010
6	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2009
5	Allopurinol (Remid)FDA LinkGeneric 12/2021 - 06/2011
5	Tumor Necrosis Factor InhibitorsIBA 07/2021 - 04/2012
5	Anti-Citrullinated Protein AntibodiesIBA 03/2020 - 05/2011
5	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 12/2002
5	bucillamine (SA 96)IBA 01/2020 - 01/2005
5	tofacitinibIBA 09/2019 - 10/2014
5	Biomarkers (Surrogate Marker)IBA 07/2019 - 01/2009
5	EnzymesIBA 11/2018 - 12/2002
5	Peptides (Polypeptides)IBA 01/2018 - 01/2013
5	Interleukin-17 (Interleukin 17)IBA 08/2017 - 10/2009
5	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 01/2009
5	Xanthine OxidaseIBA 06/2011 - 06/2011
5	purineIBA 06/2011 - 03/2011
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2022 - 01/2005
4	C-Reactive ProteinIBA 01/2021 - 01/2007
4	SteroidsIBA 01/2020 - 05/2007
4	Amino Acids FDA Link 08/2016 - 10/2013
4	Interleukin-18 (Interleukin 18)IBA 04/2014 - 10/2010
4	Therapeutic UsesIBA 08/2012 - 01/2005
3	Biosimilar PharmaceuticalsIBA 07/2022 - 03/2020
3	CT-P13IBA 07/2022 - 01/2015
3	InterleukinsIBA 07/2021 - 01/2016
3	hydroxide ionIBA 01/2021 - 07/2013
3	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 06/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 06/2011
3	sirukumabIBA 03/2019 - 01/2018
3	HLA Antigens (Human Leukocyte Antigens)IBA 10/2018 - 01/2014
3	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 12/2014 - 09/2012
3	cyclic citrullinated peptideIBA 08/2014 - 05/2011
3	Nucleic AcidsIBA 07/2012 - 04/2008
3	Matrix Metalloproteinases (MMPs)IBA 01/2010 - 01/2005
2	Chemokine CX3CL1IBA 07/2021 - 01/2021
2	quetmolimabIBA 07/2021 - 01/2021
2	olokizumabIBA 07/2021 - 01/2016
2	Immunoglobulin G (IgG)IBA 01/2021 - 05/2011
2	amsonic acid (DAS)IBA 09/2020 - 01/2017
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 01/2018
2	LigandsIBA 01/2020 - 10/2009

Therapy/Procedure

42	Therapeutics 12/2021 - 06/2004
3	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2010 - 01/2007
2	Drug Therapy (Chemotherapy) 10/2020 - 01/2003
2	Drug Tapering 05/2020 - 01/2020